The European Medicines Agency’s CHMP issues a positive opinion recommending marketing authorisation for Ponvory (ponesimod) to treat adults with relapsing forms of multiple sclerosis
Allschwil, Switzerland – March 26, 2021 Idorsia Ltd (SIX: IDIA) was informed by the Janssen Pharmaceutical Companies of Johnson &...